Physician profile
David F Corcoran
NPI 1528026044
$3,966.62
in general payments reported to CMS, 2019-2025
24 companies · $564 in 2025
The $564 reported for 2025 was more than what a typical Primary Podiatric Medicine provider received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $219 · 2021: $14.28 · 2022: $68.20 · 2023: $970 · 2024: $2,131 · 2025: $564.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,204 · Food and Beverage: $1,354 · Education: $107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,203.57 |
| Food and Beverage | $1,354.44 |
| Education | $107.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries Lp | $2,073.09 | 2023-2024 | |
| Vilex LLC | $772.89 | 2024 | |
| Forthright Medical - Az, LLC | $386.55 | 2024-2025 | Ossiofiber Compression Staple System |
| Cardiovascular Systems INC. | $145.60 | 2019 | |
| Ortho Systems | $107.12 | 2025 | |
| Medtronic, INC. | $81.88 | 2025 | Symplicity G3 |
| Horizon Therapeutics Plc | $71.37 | 2019-2023 | Krystexxa |
| Integra Lifesciences Corporation | $48.42 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Smith+Nephew, INC. | $35.12 | 2019-2023 | Renasys Go V2 Home, Pico 7 |
| Kowa Pharmaceuticals America, INC. | $33.22 | 2022-2025 | Zoryve |
| Nevro Corp. | $25.44 | 2022 | |
| Advanced Oxygen Therapy INC. | $24.48 | 2024-2025 | Topical Oxygen Chamber For Extremities |
| Amgen INC. | $19.11 | 2024 | Krystexxa |
| Orthofix Medical, INC. | $15.60 | 2024 | Physio-Stim |
| Arthrosurface Incorporated | $15.23 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $15.18 | 2023 | Puraply |
| Abbott Laboratories | $14.94 | 2023 | Proclaim |
| Bioventus LLC | $14.28 | 2021 | |
| Flower Orthopedics Coporation | $14.05 | 2025 | |
| Merck Sharp & Dohme LLC | $13.63 | 2019 | |
| Melinta Therapeutics, LLC | $12.48 | 2019 | |
| Aap Implants INC | $11.19 | 2022 | |
| Reprise Biomedical, INC. | $9.88 | 2025 | Miro3d |
| Biocomposites INC | $5.87 | 2025 | Stimulan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Corcoran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.